JP2018524973A5 - - Google Patents

Download PDF

Info

Publication number
JP2018524973A5
JP2018524973A5 JP2017562598A JP2017562598A JP2018524973A5 JP 2018524973 A5 JP2018524973 A5 JP 2018524973A5 JP 2017562598 A JP2017562598 A JP 2017562598A JP 2017562598 A JP2017562598 A JP 2017562598A JP 2018524973 A5 JP2018524973 A5 JP 2018524973A5
Authority
JP
Japan
Prior art keywords
hla
car
isolated
antibody
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017562598A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018524973A (ja
JP7010473B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/035916 external-priority patent/WO2016197064A1/en
Publication of JP2018524973A publication Critical patent/JP2018524973A/ja
Publication of JP2018524973A5 publication Critical patent/JP2018524973A5/ja
Priority to JP2021182547A priority Critical patent/JP2022051570A/ja
Application granted granted Critical
Publication of JP7010473B2 publication Critical patent/JP7010473B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017562598A 2015-06-04 2016-06-03 Lym-1およびlym-2標的化car細胞免疫療法 Expired - Fee Related JP7010473B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021182547A JP2022051570A (ja) 2015-06-04 2021-11-09 Lym-1およびlym-2標的化car細胞免疫療法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562171004P 2015-06-04 2015-06-04
US62/171,004 2015-06-04
PCT/US2016/035916 WO2016197064A1 (en) 2015-06-04 2016-06-03 Lym-1 and lym-2 targeted car cell immunotherapy

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021182547A Division JP2022051570A (ja) 2015-06-04 2021-11-09 Lym-1およびlym-2標的化car細胞免疫療法

Publications (3)

Publication Number Publication Date
JP2018524973A JP2018524973A (ja) 2018-09-06
JP2018524973A5 true JP2018524973A5 (https=) 2019-06-13
JP7010473B2 JP7010473B2 (ja) 2022-02-10

Family

ID=57441999

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017562598A Expired - Fee Related JP7010473B2 (ja) 2015-06-04 2016-06-03 Lym-1およびlym-2標的化car細胞免疫療法
JP2021182547A Pending JP2022051570A (ja) 2015-06-04 2021-11-09 Lym-1およびlym-2標的化car細胞免疫療法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021182547A Pending JP2022051570A (ja) 2015-06-04 2021-11-09 Lym-1およびlym-2標的化car細胞免疫療法

Country Status (9)

Country Link
US (2) US10711064B2 (https=)
EP (1) EP3302559B1 (https=)
JP (2) JP7010473B2 (https=)
CN (1) CN107847601A (https=)
AU (1) AU2016270474A1 (https=)
CA (1) CA2987992A1 (https=)
HK (1) HK1253549A1 (https=)
IL (1) IL256058B (https=)
WO (1) WO2016197064A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201591164A1 (ru) 2012-12-18 2015-11-30 Икан Скул Оф Медсин Эт Маунт Синай Вакцины против вируса гриппа и их применение
US9908930B2 (en) 2013-03-14 2018-03-06 Icahn School Of Medicine At Mount Sinai Antibodies against influenza virus hemagglutinin and uses thereof
KR101605421B1 (ko) 2014-03-05 2016-03-23 국립암센터 B 세포 림프종 세포를 특이적으로 인지하는 단일클론항체 및 이의 용도
EP3247389A4 (en) 2015-01-23 2019-10-30 Icahn School of Medicine at Mount Sinai INFLUENZAVIRUSSCHUTZIMPFPLÄNE
SG11201810640RA (en) * 2016-06-08 2018-12-28 Intrexon Corp Cd33 specific chimeric antigen receptors
CA3023143A1 (en) 2016-06-15 2017-12-21 Icahn School Of Medicine At Mount Sinai Influenza virus hemagglutinin proteins and uses thereof
JP2020508080A (ja) * 2017-02-21 2020-03-19 ユーティレックス カンパニー リミテッド Hla−dr car−t組成物ならびにその作製方法および使用方法
WO2018187706A2 (en) * 2017-04-07 2018-10-11 Icahn School Of Medicine At Mount Sinai Anti-influenza b virus neuraminidase antibodies and uses thereof
US20200377855A1 (en) * 2017-05-05 2020-12-03 H. Lee Moffitt Cancer Center And Research Institute, Inc. Rapid method for the culture of tumor infiltrating lymphocytes
CN110892265A (zh) * 2017-06-13 2020-03-17 拜克门寇尔特公司 通过荧光灵敏的流式细胞术检测白细胞来源的微泡
EP3810634A4 (en) 2018-06-21 2022-07-27 Icahn School of Medicine at Mount Sinai Mosaic influenza virus hemagglutinin polypeptides and uses thereof
EP3835320A4 (en) 2018-08-10 2022-06-01 Eutilex Co., Ltd. Chimeric antigen receptor binding to hla-dr, and car-t cell
TWI850282B (zh) * 2018-11-27 2024-08-01 香港商弘年發展有限公司 用於治療癌症之質體建構體和使用方法
AU2020221324A1 (en) * 2019-02-15 2021-09-02 University Of Southern California Lym-1 and Lym-2 antibody compositions and improved CAR constructs
EP3959216A4 (en) 2019-04-24 2023-01-11 Icahn School of Medicine at Mount Sinai ANTI-INFLUENZA B VIRUS NEURAMINIDASE ANTIBODIES AND USES THEREOF
MX2021015967A (es) * 2019-06-27 2022-04-06 Eutilex Co Ltd Receptor de antigeno quimerico con dominio coestimulador 4-1bb.
AU2021308078A1 (en) 2020-07-17 2023-02-09 Children's Hospital Los Angeles Chimeric MyD88 receptors for redirecting immunosuppressive signaling and related compositions and methods
TW202334400A (zh) * 2021-12-30 2023-09-01 美商Tr1X股份有限公司 表現il-10及嵌合抗原受體之cd4+ t細胞及其用途
CN117186242A (zh) * 2023-07-14 2023-12-08 上海市浦东医院(复旦大学附属浦东医院) 一种靶向vegfr2和pd-1的双靶点嵌合抗原受体及其应用
CN117106098A (zh) * 2023-07-14 2023-11-24 上海市浦东医院(复旦大学附属浦东医院) Vegfr2和pd-1双靶点三代嵌合抗原受体及其应用

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US707993A (en) 1901-05-16 1902-08-26 Clinton J Warren Machine for corking bottles.
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4724212A (en) 1985-05-24 1988-02-09 Northwestern University Murine hybridoma Lym-2 and diagnostic antibody produced thereby
US4724213A (en) 1985-05-24 1988-02-09 Northwestern University Murine hybridoma Lym-1 and diagnostic antibody produced thereby
EP0436597B1 (en) 1988-09-02 1997-04-02 Protein Engineering Corporation Generation and selection of recombinant varied binding proteins
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US6905680B2 (en) 1988-11-23 2005-06-14 Genetics Institute, Inc. Methods of treating HIV infected subjects
US6534055B1 (en) 1988-11-23 2003-03-18 Genetics Institute, Inc. Methods for selectively stimulating proliferation of T cells
US6352694B1 (en) 1994-06-03 2002-03-05 Genetics Institute, Inc. Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
US5858358A (en) 1992-04-07 1999-01-12 The United States Of America As Represented By The Secretary Of The Navy Methods for selectively stimulating proliferation of T cells
WO1991010737A1 (en) 1990-01-11 1991-07-25 Molecular Affinities Corporation Production of antibodies using gene libraries
US5780225A (en) 1990-01-12 1998-07-14 Stratagene Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US5698426A (en) 1990-09-28 1997-12-16 Ixsys, Incorporated Surface expression libraries of heteromeric receptors
CA2405246A1 (en) 1990-12-03 1992-06-11 Genentech, Inc. Enrichment method for variant proteins with alterred binding properties
DK0580737T3 (da) 1991-04-10 2004-11-01 Scripps Research Inst Heterodimere receptorbiblioteker ved anvendelse af phagemider
SE9101433D0 (sv) 1991-05-13 1991-05-13 Marianne Hansson Recombinant dna sequence and its use
CA2110799A1 (en) 1991-06-14 1992-12-23 Arnold H. Horwitz Microbially-produced antibody fragments and their conjugates
ES2341666T3 (es) 1991-12-02 2010-06-24 Medimmune Limited Produccion de autoanticuerpos de repertorios de segmentos de anticue rpos expresados en la superficie de fagos.
US5733743A (en) 1992-03-24 1998-03-31 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
EP0733070A1 (en) 1993-12-08 1996-09-25 Genzyme Corporation Process for generating specific antibodies
PT1231268E (pt) 1994-01-31 2005-11-30 Univ Boston Bancos de anticorpos policlonais
US7175843B2 (en) 1994-06-03 2007-02-13 Genetics Institute, Llc Methods for selectively stimulating proliferation of T cells
US5516637A (en) 1994-06-10 1996-05-14 Dade International Inc. Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
GB9416721D0 (en) 1994-08-18 1994-10-12 Short Brothers Plc A bias yarn assembly forming device
US5712149A (en) 1995-02-03 1998-01-27 Cell Genesys, Inc. Chimeric receptor molecules for delivery of co-stimulatory signals
US6692964B1 (en) 1995-05-04 2004-02-17 The United States Of America As Represented By The Secretary Of The Navy Methods for transfecting T cells
US7067318B2 (en) 1995-06-07 2006-06-27 The Regents Of The University Of Michigan Methods for transfecting T cells
AU725609C (en) 1995-08-18 2002-01-03 Morphosys Ag Protein/(poly)peptide libraries
JP2978435B2 (ja) 1996-01-24 1999-11-15 チッソ株式会社 アクリロキシプロピルシランの製造方法
US6924123B2 (en) 1996-10-29 2005-08-02 Oxford Biomedica (Uk) Limited Lentiviral LTR-deleted vector
ES2327382T3 (es) 1999-07-20 2009-10-29 Morphosys Ag Metodos para presentar (poli)peptidos/proteinas en particulas de bacteriofagos a traves de enlaces disulfuro.
US6867041B2 (en) 2000-02-24 2005-03-15 Xcyte Therapies, Inc. Simultaneous stimulation and concentration of cells
US6797514B2 (en) 2000-02-24 2004-09-28 Xcyte Therapies, Inc. Simultaneous stimulation and concentration of cells
CA2406864A1 (en) 2000-02-24 2001-08-30 Life Technologies Corporation Simultaneous stimulation and concentration of cells
US7419829B2 (en) 2000-10-06 2008-09-02 Oxford Biomedica (Uk) Limited Vector system
DE60226852D1 (de) 2001-03-13 2008-07-10 Novartis Ag Lentivirale verpackungskonstrukte
ES2273202T3 (es) 2003-01-07 2007-05-01 Symphogen A/S Procedimiento para producir proteinas policlonales recombinantes.
CA2518552A1 (en) 2003-03-11 2004-09-23 Genentech, Inc. Novel compositions and methods for the treatment of immune related disease
US20130266551A1 (en) 2003-11-05 2013-10-10 St. Jude Children's Research Hospital, Inc. Chimeric receptors with 4-1bb stimulatory signaling domain
EP1711527A4 (en) 2003-12-15 2008-09-03 Dendreon Corp HLA-DR SPECIFIC ANTIBODIES, COMPOSITIONS AND METHODS
GB0408449D0 (en) 2004-04-15 2004-05-19 Banerjee Subhasis Diagnostic and therapeutic applications of soluble lhcge protein
US7527947B2 (en) 2004-06-14 2009-05-05 Novozymes A/S Signal peptide for producing a polypeptide
CN1331887C (zh) * 2004-08-20 2007-08-15 上海美恩生物技术有限公司 抗hla-dr10的淋巴瘤特异性嵌合单抗
CA2577815A1 (en) 2004-08-20 2006-03-30 The Regents Of The University Of California Engineered antibody fragment that irreversibly binds an antigen
ES2665422T3 (es) * 2005-03-03 2018-04-25 Immunomedics Inc. Anticuerpos L243 humanizados
WO2007058725A2 (en) * 2005-10-12 2007-05-24 The Regents Of The University Of California Engineered antibody fragment that irreversibly binds an antigen
EP4032552B1 (en) 2008-08-26 2023-10-04 City of Hope Method and compositions for enhanced anti-tumor effector functioning of t cells
KR20110084280A (ko) 2008-11-03 2011-07-21 알레시아 바이오쎄라퓨틱스 인코포레이티드 종양 항원의 생물 활성을 특이적으로 차단하는 항체
PH12013501201A1 (en) 2010-12-09 2013-07-29 Univ Pennsylvania Use of chimeric antigen receptor-modified t cells to treat cancer
CN103041387B (zh) * 2011-10-11 2014-12-10 苏州工业园区晨健抗体组药物开发有限公司 恶性b细胞淋巴瘤抗体药物的新用途
CA3205751A1 (en) 2012-02-22 2013-08-29 The Trustees Of The University Of Pennsylvania Use of icos-based cars to enhance antitumor activity and car persistence
EA033110B1 (ru) * 2012-04-11 2019-08-30 Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез Химерный рецептор антигена, направленный на антиген созревания b-клеток, кодирующая его нуклеиновая кислота, соответствующие экспрессионный вектор, клетка-хозяин, применения и способы
US9534044B2 (en) 2013-02-28 2017-01-03 United Arab Emirates University Alpha-synuclein antibodies and uses thereof
KR101605421B1 (ko) * 2014-03-05 2016-03-23 국립암센터 B 세포 림프종 세포를 특이적으로 인지하는 단일클론항체 및 이의 용도
AU2016243124A1 (en) 2015-03-27 2017-11-02 University Of Southern California CAR T-cell therapy directed to LHR for the treatment of solid tumors
WO2016174652A1 (en) * 2015-04-30 2016-11-03 Technion Research & Development Foundation Limited Chimeric antigen receptors and methods of their use
JP2020508080A (ja) * 2017-02-21 2020-03-19 ユーティレックス カンパニー リミテッド Hla−dr car−t組成物ならびにその作製方法および使用方法

Similar Documents

Publication Publication Date Title
JP2018524973A5 (https=)
Chen et al. Characterization of a soluble B7-H3 (sB7-H3) spliced from the intron and analysis of sB7-H3 in the sera of patients with hepatocellular carcinoma
JP2018511319A5 (https=)
Loo et al. Development of an Fc-enhanced anti–B7-H3 monoclonal antibody with potent antitumor activity
Inaguma et al. Construction and molecular characterization of a T-cell receptor-like antibody and CAR-T cells specific for minor histocompatibility antigen HA-1H
Stevenson et al. The meaning and relevance of B-cell receptor structure and function in chronic lymphocytic leukemia
Jain et al. The development of a recombinant scFv monoclonal antibody targeting canine CD20 for use in comparative medicine
RU2016131207A (ru) Детерминанты ответа раковой опухоли на иммунотерапию
KR20190101989A (ko) 항 gpc3 항체
JP2022510322A (ja) Cd3抗体およびその医薬用途
WO2018097951A1 (en) Anti-mage-a3/a6 antibodies
JP2013506428A5 (https=)
Jovčevska et al. TRIM28 and β-actin identified via nanobody-based reverse proteomics approach as possible human glioblastoma biomarkers
BRPI0611194B1 (pt) Moléculas de ligação anti-cd16
WO2018071913A2 (en) Modular tetrameric bispecific antibody platform
JP6944925B2 (ja) 組織浸潤nk細胞を検出する方法
WO2013131050A1 (en) Materials and methods for differential treatment of cancer
US9676855B2 (en) B7-H6 therapeutically active monoclonal antibody against B7-H6 polypeptide
JP2021505663A5 (https=)
Cyr et al. Patient-derived Siglec-6-targeting antibodies engineered for T-cell recruitment have potential therapeutic utility in chronic lymphocytic leukemia
WO2019224385A2 (en) Combined bispecific antibody and immuno-oncology therapies
CN115667304B (zh) 抗人lag-3抗体及其在免疫组织化学(ihc)中的用途
JP2024517893A (ja) 腫瘍由来細胞外小胞に関する方法
JP2020515286A5 (https=)
JP2013512454A5 (https=)